Clinical Trial: Neuronavigated TMS targeting regulation of FPCN subnetwork for attention deficit in adolescents with major depressive disorder: a study of efficacy and safety (China)

Posted On: 2026-09-28

China, Sept. 28 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Neuronavigated TMS targeting regulation of FPCN subnetwork for attention deficit in adolescents with major depressive disorder: a study of efficacy and safety'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133455

Registration Time: 2026/09/28

Type: Interventional study

Primary Sponsor: The first hospital of Shanxi Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344335

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Neuronavigated TMS targeting regulation of FPCN subnetwork for attention deficit in adolescents with major depressive disorder: a study of efficacy and safety (China)